/PRNewswire/ Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the close.
Kineta Presenting at Multiple Investor Conferences in March 2021
News provided by
Share this article
Share this article
SEATTLE, March 3, 2021 /PRNewswire/ Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology and neuroscience announced today that Kineta will be presenting at multiple virtual investor events in March 2021. Shawn Iadonato, Kineta Chief Executive Officer and Craig Philips, President, will present an overview of the company with a focus on its novel VISTA immuno-oncology program at the following events:
Cowen 41st Annual Health Care Conference
March 1-4, 2021
March 9-10, 2021
March 11, 2021 11:20-11:40AM Pacific
Life Science Innovation Northwest